0001171843-23-002224.txt : 20230411 0001171843-23-002224.hdr.sgml : 20230411 20230410182102 ACCESSION NUMBER: 0001171843-23-002224 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230410 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230411 DATE AS OF CHANGE: 20230410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 23812019 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K/A 1 f8ka_041023.htm FORM 8-K/A
0001731348 true 0001731348 2023-04-10 2023-04-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

 

FORM 8-K/A

_________________

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 10, 2023

_______________________________

 

Tilray Brands, Inc.

(Exact name of registrant as specified in its charter)

_______________________________

 

Delaware 001-38594 82-4310622
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

 

265 Talbot Street West

Leamington, Ontario N8H 4H3

(Address of Principal Executive Offices) (Zip Code)

 

(844) 845-7291

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class 2 Common stock, par value $0.0001 per share TLRY The NASDAQ Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

EXPLANATORY NOTE

 

This Current Report on Form 8-K/A (Amendment No. 1) amends the Current Report on Form 8-K filed on April 10, 2023 (the “Original Form 8-K”) by Tilray Brands, Inc. (the “Company”) in order to correct an inadvertent deletion of two line items in the exhibits to the press release furnished as Exhibit 99.1 with the Original Form 8-K. This Form 8-K/A (Amendment No. 1) is being filed to amend the Original Form 8-K to update the disclosures made therein.

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On April 10, 2023, Tilray Brands, Inc. (“Tilray”) issued a press release announcing financial results for its third fiscal quarter ended February 28, 2023. A copy of the press release is furnished herewith as Exhibit 99.1.

The information in this current report on Form 8-K, including the press release attached as Exhibit 99.1 hereto, is being furnished, but shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Tilray, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number Description
   
99.1 Press Release of Tilray Brands, Inc., dated April 10, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Tilray Brands, Inc.
     
     
Date: April 10, 2023 By:  /s/ Mitchell Gendel        
    Mitchell Gendel
    Global General Counsel
     

 

 

 

 

 EX-99.1 2 exh_991.htm EXHIBIT 99.1 EdgarFiling

EXHIBIT 99.1

CORRECTION--Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp.

Delivered $145.6 Million in Net Revenue and 16th Consecutive Quarter of Positive Adjusted EBITDA

Maintained #1 Cannabis Market Share Position in Canada, the Largest Federally Legal Cannabis Market in the World; With HEXO Transaction, Poised to Substantially Increase Canadian Revenue

Medical Cannabis Leader in Europe

Achieved Key Efficiency Milestones on Accelerated Path to Positive Cash Flow, Company Reiterates Cash Flow Guidance

LEAMINGTON, Ontario and NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), please note that the first table, the Consolidated Statement of Financial Positions was missing the entry for “Contingent consideration” under “Long-term liabilities.” In addition, the table “Other Financial Information: Adjusted Earnings Before Interest, Taxes and Amortization” was missing the entry “Inventory valuation adjustment.” The corrected release follows:

Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported financial results for the third fiscal quarter ended February 28, 2023. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

Tilray also announces today that it entered into a definitive agreement to acquire HEXO Corp. (NASDAQ: HEXO; TSX: HEXO) for an aggregate purchase price of approximately US$56 million, to be satisfied through the issuance of 0.4352 of Tilray Common Stock for each outstanding HEXO share. The acquisition, which is structured as an arrangement under applicable Canadian laws (the “Arrangement”), builds on the successful strategic alliance between the two companies and positions Tilray for continued strong growth and market leadership in Canada, the largest federally legal cannabis market in the world.

The completion of the Arrangement is subject to customary and negotiated closing conditions, including HEXO shareholder approval and court approval, and is expected to close in June 2023. Further information about the HEXO transaction is included in an investor presentation available on the investor section of Tilray.com and in our Current Report on Form 8-K filed today.

Financial Highlights

  • Net revenue increased to $145.6 million compared to $144.1 million in the prior quarter. On a constant currency basis, net revenue was $154.2 million in the third quarter of 2023, up 2% from the prior year quarter.
  • Distribution revenue increased 5% to $65.4 million, from the prior year quarter. On a constant currency basis, distribution revenue increased 12% to $70.1 million.
  • Gross Profit (Loss) was ($11.7) million, while adjusted gross profit was $44.3 million. Gross margin was negative 8%, while adjusted gross margin rose to 30% from 26% in the year-ago quarter.
  • Adjusted cannabis gross profit increased to $22.2 million from $18.0 million in the prior year quarter, while adjusted gross margin percentage increased to 47% from 33%.
  • Achieved $22 million in annualized run-rate savings (and $12 million in actual cost savings) as part of $30 million cost optimization plan announced in Q4 of 2022; total annualized cash cost-savings since the closing of the Tilray-Aphria transaction reached $122 million.
  • Adjusted EBITDA of $14.0 million, marking 16th consecutive quarter of positive adjusted EBITDA. Currently expecting Adjusted EBITDA in the range of $60 to $66 million, a greater than 30% increase from the prior year.
  • Strong financial position with $408.3 million in cash and marketable securities.
  • Reiterated expectation to deliver positive free cash flow from operating segments in fiscal 2023.
  • Recorded non-cash $1.1 billion net asset reduction resulting from higher interest rates and a decline in market capitalization. This non-cash net asset reduction has no impact on the Company’s compliance with debt covenants, its cash flows or available liquidity.

Irwin D. Simon, Tilray Brands’ Chairman and Chief Executive Officer, stated, “During the quarter, we continued to focus on our highest priorities: sustaining and growing the top-line across core markets and geographies while optimizing the platform to achieve positive free cash flow on an accelerated timeline. We are executing on both fronts and delivered revenue growth despite challenging market dynamics across Canada, Europe, and the U.S, as well as our 16th consecutive quarter of positive adjusted EBITDA.”

Mr. Simon continued, “Looking ahead, we are focused on being the leading, most diversified cannabis lifestyle and CPG company in the world. Our strategy to deliver on this vision is centered on pursuing targeted growth opportunities, as reflected in our opportunistic acquisitions of both Montauk Brewing Company and HEXO, which has made significant strides in driving operating efficiency and improving profitability while continuing to invest in industry-leading brands. We are incredibly excited about our combined prospects moving forward with HEXO and expect a seamless integration of HEXO’s business into our efficient, built-to-last platform. At the same time, we will continue our relentless focus on cost and operational efficiencies and strengthening our industry-leading balance sheet to deliver sustained, profitable growth and shareholder value.”

Mark Attanasio, Chairman of HEXO, said, “Over the past year, HEXO established and has been executing on a rigorous cost-cutting and balance sheet optimization plan.  As we began working with Tilray last year, the value that could be achieved through the combination of our businesses in order to compete and drive profitable growth in the highly fragmented Canadian market was immediately clear. With the recent headwinds in the cannabis industry, our Board determined that HEXO shareholders would benefit from being part of Tilray’s diversified business and from the strong plan in place they have to reinforce their industry leadership, continue to strengthen the top and bottom lines, and to drive value creation. With Irwin and his leadership team, we are confident that our brands will continue to grow and thrive as part of Tilray Brands.”

Operating Highlights

Leadership in Global Cannabis Operations, Brands, and Market Share:

  • In Canada, despite ongoing challenging cannabis market conditions, quarter over quarter, Tilray maintained its #1 cannabis market share position. With the addition of HEXO’s leading high-growth brands, the Company expects to significantly bolster its position supported by low-cost operations and complimentary distribution across all Canadian geographies. The combined company is expected to strengthen Tilray’s existing Canadian position with 12.9% pro-forma market share and #1 market position across all major markets and a leading share across most product categories. This includes anticipated pro-forma net sales of approximately US$215M and the leading low-cost operations with distribution across all Canadian geographies.

  • Capitalizing on the unrivaled platform provided by its cultivation and distribution operations across Portugal and Germany and the leadership team’s depth of commercial and regulatory expertise, Tilray is focused on growing its leading market share in medical cannabis in the countries in which it distributes today and achieving early-mover advantage in new countries as cannabis legalization continues to proliferate across Europe.

Maximizing the High-Growth Potential of U.S. CPG and Craft-Beverage Portfolio:

  • In the third quarter, Tilray made substantial strides across its five craft-beverage brands including leaders SweetWater Brewing Company, Breckenridge Distillery, and Montauk Brewing Company, and its wellness brand Manitoba Harvest. By expanding recognition and distribution, Tilray will be well positioned to immediately leverage these brands to drive significant additional revenue in adult-use cannabis, pending federal legalization.

Strategic Growth Actions

  • April 2023 – Tilray Medical Expands Footprint in Europe and Broadens Distribution Across the Czech Republic
  • April 2023 – SweetWater Brewing Company Expands Across 44 States with Nevada Launch
  • April 2023 - Manitoba Harvest Expands Whole Foods Market Distribution
  • April 2023 - Breckenridge Distillery Wins Big at Whisky Magazine’s 2023 World Whiskies Awards
  • March 2023 - Alpine Beer Opens Taproom at Petco Park Stadium in San Diego
  • March 2023 - Breckenridge Distillery Establishes March 31st as National Après Day
  • March 2023 - Montauk Brewing Expands Distribution Across the Northeast
  • March 2023 - Tilray Brands Stockholders Approve Charter Amendment to Enhance Corporate Governance and Support Strategic Growth Plan
  • March 2023 - SweetWater Brewing Company Brings Back Popular Triple Tail Tropical India Pale Ale
  • March 2023 - SweetWater Brewing Company Introduces New West Coast Style India Pale Ale
  • March 2023 - Potently Canadian Cannabis Brand, CANACA, Introduces New Collection of Terpene Rich Products Across Canada
  • February 2023 - Good Supply Cannabis Brand Launches Canada’s Strongest Infused Pre-Rolls
  • February 2023 - Breckenridge Distillery Strikes Gold at 2023 World Whiskies Awards
  • February 2023 - Good Supply Cannabis Brand Launches New Product Lineup
  • February 2023 - SweetWater Announces 420 Fest 2023 Lineup and Venue
  • February 2023 - Breckenridge Distillery Launches Limited-Edition Sexy Motor Oil Whiskey for Valentine’s Day
  • February 2023 - SweetWater Brewing Company Introduces New Crisp Lager to Year-Round Lineup
  • January 2023 - Alpine Beer Launches INFINITE HAZE Hazy IPA
  • January 2023 - Solei Cannabis Brand Introduces New Approach to Wellness with New Product Lineup and Brand Refresh
  • January 2023 - SweetWater Brewing Company Celebrates 26 Years of Brewing with Throwback Beers, Jam Bands

Live Conference Call and Audio Webcast
Tilray Brands will host a webcast to discuss these results today at 5:00 p.m. ET. Investors may join the live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will also be archived after the call concludes.

About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Patients and consumers trust Tilray Brands to be the most responsible, trusted and market leading cannabis consumer products company in the world with a portfolio of innovative, high-quality and beloved brands that address the needs of the consumers, customers and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray Brands’ unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on Tilray Brands, visit www.Tilray.com and follow @Tilray

Cautionary Statement Concerning Forward-Looking Statements

Certain statements in this press release constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication.

Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the Company’s ability to become the world's leading cannabis-focused consumer branded company; the Company’s ability to generate its targeted amount of Adjusted EBITDA for the fiscal year ending May 31, 2023; the Company’s expectation to be free-cash flow positive in its operating business units; the Company’s ability to achieve long term profitability; the Company’s ability to achieve operational scale, market share, distribution, profitability and revenue growth in particular business lines and markets; the Company’s ability to successfully complete the acquisition of HEXO; the Company’s ability to successfully achieve revenue growth, production and supply chain efficiencies, synergies and cost savings, including with respect to the HEXO acquisition; expansion of medical and recreational sales legalization across the global cannabis industry, including in Europe; and the Company’s anticipated investments and acquisitions, including in organic and strategic growth, partnership efforts, product offerings and other initiatives.

Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of the Company and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of the Company made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Use of Non-U.S. GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including adjusted gross margin, Adjusted gross profit, Adjusted EBITDA, Adjusted net income and free cash flow. Management believes that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the Company's operations and are useful for period-over-period comparisons of operations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the Company's Consolidated Statements of Operations and Cash Flows presented in accordance with GAAP.

Certain forward-looking non-GAAP financial measures included in this press release are not reconciled to the comparable forward-looking GAAP financial measures. The Company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the Company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Such items may include litigation and related expenses, transaction costs, impairments, foreign exchange movements and other items. The unavailable information could have a significant impact on the Company's GAAP financial results.

The Company believes presenting net sales at constant currency provides useful information to investors because it provides transparency to underlying performance in the Company's consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year.

Adjusted EBITDA is calculated as net income (loss) before income tax expense (recovery); interest expense, net; non-operating income (expense), net; amortization; stock-based compensation; change in fair value of contingent consideration; impairments; purchase price accounting step-up; facility start-up and closure costs; lease expense; litigation (recovery) costs; restructuring costs; and transaction (income) costs. A reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Adjusted gross profit, is calculated as gross profit adjusted to exclude the impact of inventory valuation adjustment and purchase price accounting valuation step-up. A reconciliation of Adjusted gross profit, excluding inventory valuation adjustments and purchase price accounting valuation step-up, to gross profit, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Adjusted gross margin, excluding inventory valuation adjustments and purchase price accounting valuation step-up, is calculated as revenue less cost of sales adjusted to add back inventory valuation adjustments and amortization of inventory step-up, divided by revenue. A reconciliation of Adjusted gross margin, excluding inventory valuation adjustments and purchase price accounting valuation step-up, to gross margin, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Adjusted net income is calculated as net (loss) income plus (minus) non-operating income (expense), net, change in fair value of contingent consideration, impairments; inventory write down, litigation (recovery) costs, restructuring costs, and transaction (income) costs. A reconciliation of Adjusted net income, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Free cash flow is comprised of two GAAP measures deducted from each other which are net cash flow provided by (used in) operating activities less investments in capital and intangible assets. A reconciliation of net cash flow provided by (used in) operating activities to free cash flow, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release.

For further information:

Media: Berrin Noorata, news@tilray.com
Investors: Raphael Gross, +1-203-682-8253, Raphael.Gross@icrinc.com

 

Consolidated Statements of Financial Position        
    February 28,   May 31,
(in thousands of US dollars)     2023       2022  
Assets        
Current assets        
Cash and cash equivalents   $ 164,997     $ 415,909  
Marketable Securities     243,286       -  
Accounts receivable, net     78,342       95,279  
Inventory     202,800       245,529  
Prepaids and other current assets     69,087       46,786  
Total current assets     758,512       803,503  
Capital assets     425,263       587,499  
Right-of-use assets     6,492       12,996  
Intangible assets     994,325       1,277,875  
Goodwill     2,005,701       2,641,305  
Interest in equity investees     4,638       4,952  
Long-term investments     7,620       10,050  
Convertible notes receivable     168,356       111,200  
Other assets     4,993       314  
Total assets   $ 4,375,900     $ 5,449,694  
Liabilities        
Current liabilities        
Bank indebtedness   $ 18,125     $ 18,123  
Accounts payable and accrued liabilities     163,422       157,431  
Contingent consideration     16,219       16,007  
Warrant liability     7,414       14,255  
Current portion of lease liabilities     2,528       6,703  
Current portion of long-term debt     77,892       67,823  
Current portion of convertible debentures payable     184,082       -  
Total current liabilities     469,682       280,342  
Long - term liabilities        
Contingent consideration     10,596       -  
Lease liabilities     8,598       11,329  
Long-term debt     89,419       117,879  
Convertible debentures payable     223,087       401,949  
Deferred tax liabilities     164,412       196,638  
Other liabilities     3,335       191  
Total liabilities     969,129       1,008,328  
Commitments and contingencies (refer to Note 17)        
Stockholders' equity        
Common stock ($0.0001 par value; 980,000,000 shares authorized; 617,857,031 and 532,674,887 shares issued and outstanding, respectively)     62       53  
Series A Preferred Stock ($0.0001 par value; 10,000,000 shares authorized; 120,000 and nil shares issued and outstanding, respectively)     -       -  
Additional paid-in capital     5,723,342       5,382,367  
Accumulated other comprehensive loss     (42,948 )     (20,764 )
Accumulated Deficit     (2,276,794 )     (962,851 )
Total Tilray Brands, Inc. stockholders' equity     3,403,662       4,398,805  
Non-controlling interests     3,109       42,561  
Total stockholders' equity     3,406,771       4,441,366  
Total liabilities and stockholders' equity   $ 4,375,900     $ 5,449,694  
         

 

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)                      
    For the three months           For the nine months          
    ended February 28,   Change   % Change   ended February 28,   Change   % Change  
(in thousands of U.S. dollars, except for per share data)     2023       2022     2023 vs. 2022     2023       2022     2023 vs. 2022  
Net revenue   $ 145,589     $ 151,871     $ (6,282 )   (4 )%   $ 442,936     $ 475,047     $ (32,111 )   (7 )%  
Cost of goods sold     157,288       112,042       45,246     40 %     363,139       351,497       11,642     3 %  
Gross profit (loss)     (11,699 )     39,829       (51,528 )   (129 )%     79,797       123,550       (43,753 )   (35 )%  
Operating expenses:                                  
General and administrative     38,999       38,445       554     1 %     117,385       121,401       (4,016 )   (3 )%  
Selling     6,452       8,641       (2,189 )   (25 )%     25,792       25,283       509     2 %  
Amortization     23,518       24,590       (1,072 )   (4 )%     71,872       84,345       (12,473 )   (15 )%  
Marketing and promotion     7,354       7,578       (224 )   (3 )%     23,137       20,163       2,974     15 %  
Research and development     171       164       7     4 %     502       1,464       (962 )   (66 )%  
Change in fair value of contingent consideration     352       (30,747 )     31,099     (101 )%     563       (29,065 )     29,628     (102 )%  
Impairments     1,115,376       —       1,115,376     NM     1,115,376       —       1,115,376     NM  
Litigation (recovery) costs     (5,230 )     4,215       (9,445 )   (224 )%     (1,970 )     6,489       (8,459 )   (130 )%  
Restructuring costs     2,663       —       2,663     0 %     10,727       795       9,932     1249 %  
Transaction (income) costs     5,382       5,023       359     7 %     (3,882 )     35,653       (39,535 )   (111 )%  
Total operating expenses     1,195,037       57,909       1,137,128     1964 %     1,359,502       266,528       1,092,974     410 %  
Operating loss     (1,206,736 )     (18,080 )     (1,188,656 )   6574 %     (1,279,705 )     (142,978 )     (1,136,727 )   795 %  
Interest expense, net     (1,040 )     (2,312 )     1,272     (55 )%     (8,560 )     (22,422 )     13,862     (62 )%  
Non-operating income (expense), net     1,213       71,037       (69,824 )   (98 )%     (50,229 )     186,329       (236,558 )   (127 )%  
(Loss) income before income taxes     (1,206,563 )     50,645       (1,257,208 )   (2,482 )%     (1,338,494 )     20,929       (1,359,423 )   (6,495 )%  
Income taxes (benefit) expense     (10,811 )     (1,830 )     (8,981 )   491 %     (15,313 )     (2,739 )     (12,574 )   459 %  
Net (loss) income   $ (1,195,752 )   $ 52,475     $ (1,248,227 )   (2,379 )%     (1,323,181 )     23,668       (1,346,849 )   (5,691 )%  
Net loss per share - basic and diluted   $ (1.90 )   $ 0.09     $ (1.99 )   (2,214 )%   $ (2.20 )   $ 0.00     $ (2.20 )   (77,239 )%  
                                   


Condensed Consolidated Statements of Cash Flows                  
    For the nine months          
    ended February 28,   Change   % Change  
(in thousands of US dollars)     2023       2022     2023 vs. 2022  
Cash used in operating activities:                  
Net (loss) income   $ (1,323,181 )   $ 23,668     $ (1,346,849 )   (5691 )%  
Adjustments for:                  
Deferred income tax recovery     (29,537 )     (17,296 )     (12,241 )   71 %  
Unrealized foreign exchange loss     13,711       1,699       12,012     707 %  
Amortization     101,156       113,824       (12,668 )   (11 )%  
Loss (gain) on sale of capital assets     (2 )     (631 )     629     (100 )%  
Inventory valuation write down     55,000       12,000       43,000     358 %  
Impairments     1,115,376       -       1,115,376     0 %  
Other non-cash items     12,933       962       11,971     1244 %  
Stock-based compensation     29,766       27,025       2,741     10 %  
Loss (gain) on long-term investments & equity investments     2,843       (2,401 )     5,244     (218 )%  
Loss (gain) on derivative instruments     13,534       (210,653 )     224,187     (106 )%  
Change in fair value of contingent consideration     563       (29,065 )     29,628     (102 )%  
Change in non-cash working capital:                  
Accounts receivable     18,053       (458 )     18,511     (4042 )%  
Prepaids and other current assets     (32,680 )     (953 )     (31,727 )   3329 %  
Inventory     (11,808 )     (16,512 )     4,704     (28 )%  
Accounts payable and accrued liabilities     (1,419 )     (57,947 )     56,528     (98 )%  
Net cash used in operating activities     (35,692 )     (156,738 )     121,046     (77 )%  
Cash used in investing activities:                  
Investment in capital and intangible assets     (8,394 )     (28,470 )     20,076     (71 )%  
Proceeds from disposal of capital and intangible assets     2,175       11,526       (9,351 )   (81 )%  
Purchase of marketable securities, net     (243,186 )     -       (243,186 )   0 %  
Net cash paid for business acquisition     (28,122 )     326       (28,448 )   (8726 )%  
Net cash used in investing activities     (277,527 )     (16,618 )     (260,909 )   1570 %  
Cash provided by (used in) financing activities:                  
Share capital issued, net of cash issuance costs     129,593       —       129,593     0 %  
Shares effectively repurchased for employee withholding tax     (1,189 )     (3,149 )     1,960     (62 )%  
Proceeds from long-term debt     1,288       —       1,288     0 %  
Repayment of long-term debt and convertible debt     (64,658 )     (34,570 )     (30,088 )   87 %  
Repayment of lease liabilities     (1,114 )     (4,672 )     3,558     (76 )%  
Net increase in bank indebtedness     2       8,779       (8,777 )   (100 )%  
Net cash provided by (used in) financing activities     63,922       (33,612 )     97,534     (290 )%  
Effect of foreign exchange on cash and cash equivalents     (1,615 )     (2,284 )     669     (29 )%  
Net decrease in cash and cash equivalents     (250,912 )     (209,252 )     (41,660 )   20 %  
Cash and cash equivalents, beginning of period     415,909       488,466       (72,557 )   (15 )%  
Cash and cash equivalents, end of period   $ 164,997     $ 279,214     $ (114,217 )   (41 )%  
                   

 

Other Financial Information: Key Operating Metrics                
    For the three months   For the nine months
    ended February 28,   ended February 28,
(in thousands of U.S. dollars)     2023       2022       2023       2022  
Net cannabis revenue   $ 47,549     $ 55,045     $ 156,017     $ 184,269  
Distribution revenue     65,385       62,532       186,158       198,587  
Net beverage alcohol revenue     20,640       19,597       62,689       48,765  
Wellness revenue     12,015       14,697       38,072       43,426  
Cannabis costs     77,604       37,042       137,800       122,492  
Beverage alcohol costs     10,663       8,091       32,932       20,674  
Distribution costs     57,964       57,566       165,443       178,093  
Wellness costs     8,299       9,343       26,964       30,238  
Adjusted gross profit (excluding PPA step-up and inventory valuation adjustments) (1)     44,310       39,829       138,020       135,550  
Cannabis adjusted gross margin (excluding inventory valuation adjustments) (1)     47 %     33 %     47 %     40 %
Beverage alcohol adjusted gross margin (excluding PPA step-up) (1)     53 %     59 %     53 %     58 %
Distribution gross margin     11 %     8 %     11 %     10 %
Wellness gross margin     31 %     36 %     29 %     30 %
Adjusted EBITDA (1)     14,015       10,086       39,254       36,543  
Cash and cash equivalents and marketable securities     408,283       279,214       408,283       279,214  
Working capital     288,830       413,358       288,830       413,358  
                 

 

Net Revenue by Operating Segment                                
    For the three months   % of Total Revenue   For the three months   % of Total Revenue   For the nine months   % of Total Revenue   For the nine months   % of Total Revenue
(In thousands of U.S. dollars)   February 28, 2023     February 28, 2022     February 28, 2023     February 28, 2022  
Cannabis business   $ 47,549     33%     $ 55,045     36%     $ 156,017     35%     $ 184,269     39%  
Distribution business     65,385     45%       62,532     41%       186,158     42%       198,587     42%  
Beverage alcohol business     20,640     14%       19,597     13%       62,689     14%       48,765     10%  
Wellness business     12,015     8%       14,697     10%       38,072     9%       43,426     9%  
Total net revenue   $ 145,589     100%     $ 151,871     100%     $ 442,936     100%     $ 475,047     100%  
                                 
Net Revenue by Operating Segment in Constant Currency                            
                                 
    For the three months       For the three months       For the nine months       For the nine months    
    February 28, 2023       February 28, 2022       February 28, 2023       February 28, 2022    
(In thousands of U.S. dollars)   as reported in constant currency   % of Total Revenue   as reported in constant currency   % of Total Revenue   as reported in constant currency   % of Total Revenue   as reported in constant currency   % of Total Revenue
Cannabis business   $ 51,007     33%     $ 55,045     36%     $ 164,746     34%     $ 184,269     39%  
Distribution business     70,144     45%       62,532     41%       211,676     44%       198,587     42%  
Beverage alcohol business     20,640     14%       19,597     13%       62,689     13%       48,765     10%  
Wellness business     12,385     8%       14,697     10%       39,144     8%       43,426     9%  
Total net revenue   $ 154,176     100%     $ 151,871     100%     $ 478,255     99%     $ 475,047     100%  
                                 
                                 
Net Cannabis Revenue by Market Channel                                
    For the three months   % of Total Revenue   For the three months   % of Total Revenue   For the nine months   % of Total Revenue   For the nine months   % of Total Revenue
(In thousands of U.S. dollars)   February 28, 2023     February 28, 2022     February 28, 2023     February 28, 2022  
Revenue from Canadian medical cannabis products   $ 6,035     13%     $ 7,050     13%     $ 18,920     12%     $ 23,353     13%  
Revenue from Canadian adult-use cannabis products   45,318     96%       43,504     79%       156,063     100%       162,632     87%  
Revenue from wholesale cannabis products     58     0%       2,804     5%       686     0%       6,763     4%  
Revenue from international cannabis products     9,707     20%       15,820     29%       27,834     18%       39,792     22%  
Less excise taxes     (13,569 )   -29%       (14,133 )   -26%       (47,486 )   -30%       (48,271 )   -26%  
Total   $ 47,549     100%     $ 55,045     100%     $ 156,017     100%     $ 184,269     100%  
                                 
                                 
Net Cannabis Revenue by Market Channel in Constant Currency                            
    For the three months       For the three months       For the nine months       For the nine months    
    February 28, 2023       February 28, 2022       February 28, 2023       February 28, 2022    
(In thousands of U.S. dollars)   as reported in constant currency   % of Total Revenue   as reported in constant currency   % of Total Revenue   as reported in constant currency   % of Total Revenue   as reported in constant currency   % of Total Revenue
Revenue from Canadian medical cannabis products   $ 6,442     13%     $ 7,050     13%     $ 20,093     12%     $ 23,353     13%  
Revenue from Canadian adult-use cannabis products   48,721     96%       43,504     79%       162,777     99%       162,632     87%  
Revenue from wholesale cannabis products     62     0%       2,804     5%       726     0%       6,763     4%  
Revenue from international cannabis products     10,269     20%       15,820     29%       31,627     19%       39,792     22%  
Less excise taxes     (14,487 )   -28%       (14,133 )   -26%       (50,477 )   -31%       (48,271 )   -26%  
Total   $ 51,007     100%     $ 55,045     100%     $ 164,746     100%     $ 184,269     100%  
                                 


Other Financial Information: Gross Margin and Adjusted Gross Margin            
    For the three months ended February 28, 2023
(In thousands of U.S. dollars)   Cannabis   Beverage   Distribution   Wellness   Total
Net revenue   $ 47,549     $ 20,640     $ 65,385     $ 12,015     $ 145,589  
Cost of goods sold     80,362       10,663       57,964       8,299       157,288  
Gross profit     (32,813 )     9,977       7,421       3,716       (11,699 )
Gross margin     -69%       48%       11%       31%       -8%  
Adjustments:                    
Inventory valuation adjustments     55,000       -       -       -       55,000  
Purchase price accounting step-up     -       1,009       -       -       1,009  
Adjusted gross profit     22,187       10,986       7,421       3,716       44,310  
Adjusted gross margin     47%       53%       11%       31%       30%  
                     
    For the three months ended February 28, 2022
(In thousands of U.S. dollars)   Cannabis   Beverage   Distribution   Wellness   Total
Net revenue   $ 55,045     $ 19,597     $ 62,532     $ 14,697     $ 151,871  
Cost of goods sold     37,042       8,091       57,566       9,343       112,042  
Gross profit     18,003       11,506       4,966       5,354       39,829  
Gross margin     33%       59%       8%       36%       26%  
                     
    For the nine months ended February 28, 2023
(In thousands of U.S. dollars)   Cannabis   Beverage   Distribution   Wellness   Total
Net revenue   $ 156,017     $ 62,689     $ 186,158     $ 38,072     $ 442,936  
Cost of goods sold     137,800       32,932       165,443       26,964       363,139  
Gross profit     18,217       29,757       20,715       11,108       79,797  
Gross margin     12%       47%       11%       29%       18%  
Adjustments:                    
Inventory valuation adjustments     55,000       -       -       -       55,000  
Purchase price accounting step-up     -       3,223       -       -       3,223  
Adjusted gross profit     73,217       32,980       20,715       11,108       138,020  
Adjusted gross margin     47%       53%       11%       29%       31%  
                     
    For the nine months ended February 28, 2022
(In thousands of U.S. dollars)   Cannabis   Beverage   Distribution   Wellness   Total
Net revenue   $ 184,269     $ 48,765     $ 198,587     $ 43,426     $ 475,047  
Cost of goods sold     122,492       20,674       178,093       30,238       351,497  
Gross profit     61,777       28,091       20,494       13,188       123,550  
Gross margin     34%       58%       10%       30%       26%  
Adjustments:                    
Inventory valuation adjustments     12,000       -       -       -       12,000  
Adjusted gross profit     73,777       28,091       20,494       13,188       135,550  
Adjusted gross margin     40%       58%       10%       30%       29%  
                     


Other Financial Information: Adjusted Earnings Before Interest, Taxes and Amortization                    
    For the three months           For the nine months        
    ended February 28,   Change   % Change   ended February 28,   Change   % Change
(In thousands of U.S. dollars)     2023       2022     2023 vs. 2022     2023       2022     2023 vs. 2022
Net (loss) income   $ (1,195,752 )   $ 52,475     $ (1,248,227 )   (2,379 )%   $ (1,323,181 )   $ 23,668     $ (1,346,849 )   (5,691 )%
Income taxes (benefit) expense     (10,811 )     (1,830 )     (8,981 )   491 %     (15,313 )     (2,739 )     (12,574 )   459 %
Interest expense, net     1,040       2,312       (1,272 )   (55 )%     8,560       22,422       (13,862 )   (62 )%
Non-operating income (expense), net     (1,213 )     (71,037 )     69,824     (98 )%     50,229       (186,329 )     236,558     (127 )%
Amortization     33,769       37,020       (3,251 )   (9 )%     101,156       113,824       (12,668 )   (11 )%
Stock-based compensation     9,630       9,355       275     3 %     29,766       27,025       2,741     10 %
Change in fair value of contingent consideration     352       (30,747 )     31,099     (101 )%     563       (29,065 )     29,628     (102 )%
Impairments     1,115,376       -       1,115,376     NM     1,115,376       -       1,115,376     NM
Inventory valuation adjustments     55,000       -       55,000     NM     55,000       12,000       43,000     358 %
Purchase price accounting step-up     1,009       -       1,009     NM     3,223       -       3,223     NM
Facility start-up and closure costs     2,100       2,500       (400 )   (16 )%     6,900       10,400       (3,500 )   (34 )%
Lease expense     700       800       (100 )   (13 )%     2,100       2,400       (300 )   (13 )%
Litigation (recovery) costs     (5,230 )     4,215       (9,445 )   (224 )%     (1,970 )     6,489       (8,459 )   (130 )%
Restructuring costs     2,663       -       2,663     NM     10,727       795       9,932     1249 %
Transaction (income) costs     5,382       5,023       359     7 %     (3,882 )     35,653       (39,535 )   (111 )%
Adjusted EBITDA   $ 14,015     $ 10,086     $ 3,929     39 %   $ 39,254     $ 36,543     $ 2,711     7 %
                                 
                                 
Other Financial Information: Adjusted Net Loss                                
    For the three months           For the nine months        
    ended February 28,   Change   % Change   ended February 28,   Change   % Change
(In thousands of U.S. dollars)     2023       2022     2023 vs. 2022     2023       2022     2023 vs. 2022
Net (loss) income   $ (1,195,752 )   $ 52,475     $ (1,248,227 )   (2,379 )%   $ (1,323,181 )   $ 23,668     $ (1,346,849 )   (5,691 )%
Non-operating income (expense), net     (1,213 )     (71,037 )     69,824     (98 )%     50,229       (186,329 )     236,558     (127 )%
Change in fair value of contingent consideration     352       (30,747 )     31,099     (101 )%     563       (29,065 )     29,628     (102 )%
Impairments     1,115,376       -       1,115,376     NM     1,115,376       -       1,115,376     NM
Inventory valuation adjustments     55,000       -       55,000     NM     55,000       12,000       43,000     358 %
Litigation (recovery) costs     (5,230 )     4,215       (9,445 )   (224 )%     (1,970 )     6,489       (8,459 )   (130 )%
Restructuring costs     2,663       -       2,663     NM     10,727       795       9,932     1249 %
Transaction (income) costs     5,382       5,023       359     7 %     (3,882 )     35,653       (39,535 )   (111 )%
Adjusted net loss   $ (23,422 )   $ (40,071 )   $ 16,649     (42 )%   $ (97,138 )   $ (136,789 )   $ 39,651     (29 )%
Adjusted net loss per share - basic and diluted   $ (0.04 )   $ (0.08 )   $ 0.04     (54 )%   $ (0.16 )   $ (0.29 )   $ 0.13     (44 )%
                                 
                                 
Other Financial Information: Free Cash Flow                                
    For the three months           For the nine months        
    ended February 28,   Change   % Change   ended February 28,   Change   % Change
(In thousands of U.S. dollars)     2023       2022     2023 vs. 2022     2023       2022     2023 vs. 2022
Net cash used in operating activities   $ (18,632 )   $ (46,390 )   $ 27,758     (60 )%   $ (35,692 )   $ (156,738 )   $ 121,046     (77 )%
Less: investments in capital and intangible assets, net     (842 )     (1,352 )     510     (38 )%     (6,219 )     (16,944 )     10,725     (63 )%
Free cash flow   $ (19,474 )   $ (47,742 )   $ 28,268     (59 )%   $ (41,911 )   $ (173,682 )   $ 131,771     (76 )%
                                 

EX-101.SCH 3 tlry-20230410.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 tlry-20230410_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name EX-101.PRE 5 tlry-20230410_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Apr. 10, 2023
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description This Current Report on Form 8-K/A (Amendment No. 1) amends the Current Report on Form 8-K filed on April 10, 2023 (the “Original Form 8-K”) by Tilray Brands, Inc. (the “Company”) in order to correct an inadvertent deletion of two line items in the exhibits to the press release furnished as Exhibit 99.1 with the Original Form 8-K. This Form 8-K/A (Amendment No. 1) is being filed to amend the Original Form 8-K to update the disclosures made therein.
Document Period End Date Apr. 10, 2023
Entity File Number 001-38594
Entity Registrant Name Tilray Brands, Inc.
Entity Central Index Key 0001731348
Entity Tax Identification Number 82-4310622
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 265 Talbot Street West
Entity Address, City or Town Leamington
Entity Address, State or Province ON
Entity Address, Postal Zip Code N8H 4H3
City Area Code (844)
Local Phone Number 845-7291
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class 2 Common stock, par value $0.0001 per share
Trading Symbol TLRY
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Information, Former Legal or Registered Name Not Applicable

XML 7 f8ka_041023_htm.xml IDEA: XBRL DOCUMENT 0001731348 2023-04-10 2023-04-10 iso4217:USD shares iso4217:USD shares 0001731348 true 8-K/A 2023-04-10 Tilray Brands, Inc. DE 001-38594 82-4310622 265 Talbot Street West Leamington ON N8H 4H3 (844) 845-7291 Not Applicable false false false false Class 2 Common stock, par value $0.0001 per share TLRY NASDAQ false This Current Report on Form 8-K/A (Amendment No. 1) amends the Current Report on Form 8-K filed on April 10, 2023 (the “Original Form 8-K”) by Tilray Brands, Inc. (the “Company”) in order to correct an inadvertent deletion of two line items in the exhibits to the press release furnished as Exhibit 99.1 with the Original Form 8-K. This Form 8-K/A (Amendment No. 1) is being filed to amend the Original Form 8-K to update the disclosures made therein. EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://TLRY/role/Cover Cover Cover 1 false false All Reports Book All Reports f8ka_041023.htm exh_991.htm tlry-20230410.xsd tlry-20230410_lab.xml tlry-20230410_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8ka_041023.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "f8ka_041023.htm" ] }, "labelLink": { "local": [ "tlry-20230410_lab.xml" ] }, "presentationLink": { "local": [ "tlry-20230410_pre.xml" ] }, "schema": { "local": [ "tlry-20230410.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 60, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "TLRY", "nsuri": "http://TLRY/20230410", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "f8ka_041023.htm", "contextRef": "From2023-04-10to2023-04-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://TLRY/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "f8ka_041023.htm", "contextRef": "From2023-04-10to2023-04-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://TLRY/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001171843-23-002224-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-23-002224-xbrl.zip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end